Publication Date
In 2025 | 0 |
Since 2024 | 0 |
Since 2021 (last 5 years) | 0 |
Since 2016 (last 10 years) | 0 |
Since 2006 (last 20 years) | 1 |
Descriptor
Behavior Disorders | 2 |
Children | 2 |
Drug Therapy | 2 |
Rating Scales | 2 |
Symptoms (Individual… | 2 |
Academic Achievement | 1 |
Adolescents | 1 |
Attention | 1 |
Attention Deficit Disorders | 1 |
Attention Deficit… | 1 |
Behavior Modification | 1 |
More ▼ |
Author
Busner, J. | 1 |
Casat, C. | 1 |
Dittmann, R. | 1 |
Hain, Lisa A. | 1 |
Hale, James B. | 1 |
Harder, D. | 1 |
Heiligenstein, J. | 1 |
Jones, Nicole | 1 |
Kaplan, S. | 1 |
Lawrence, Kyle | 1 |
Morley, Jessica | 1 |
More ▼ |
Publication Type
Journal Articles | 2 |
Reports - Evaluative | 1 |
Reports - Research | 1 |
Education Level
Elementary Education | 1 |
Grade 1 | 1 |
Grade 10 | 1 |
Grade 11 | 1 |
Grade 2 | 1 |
Grade 3 | 1 |
Grade 4 | 1 |
Grade 5 | 1 |
Grade 7 | 1 |
Grade 8 | 1 |
Grade 9 | 1 |
More ▼ |
Audience
Location
Laws, Policies, & Programs
Assessments and Surveys
Conners Rating Scales | 2 |
Child Behavior Checklist | 1 |
Conners Teacher Rating Scale | 1 |
Continuous Performance Test | 1 |
Stroop Color Word Test | 1 |
Trail Making Test | 1 |
What Works Clearinghouse Rating
Hale, James B.; Reddy, Linda A.; Semrud-Clikeman, Margaret; Hain, Lisa A.; Whitaker, James; Morley, Jessica; Lawrence, Kyle; Smith, Alex; Jones, Nicole – Journal of Learning Disabilities, 2011
Methylphenidate (MPH) often ameliorates attention-deficit/hyperactivity disorder (ADHD) behavioral dysfunction according to "indirect" informant reports and rating scales. The standard of care behavioral MPH titration approach seldom includes "direct" neuropsychological or academic assessment data to determine treatment…
Descriptors: Academic Achievement, Attention Deficit Hyperactivity Disorder, Rating Scales, Short Term Memory
Kaplan, S.; Heiligenstein, J.; West, S.; Busner, J.; Harder, D.; Dittmann, R.; Casat, C.; Wernicke, J. F. – Journal of Attention Disorders, 2004
Objective: To compare the safety and efficacy of atomoxetine, a selective inhibitor of the norepinephrine transporter, versus placebo in Attention-Deficit/Hyperactivity Disorder (ADHD) patients with comorbid Oppositional Defiant Disorder (ODD). Methods: A subset analysis of 98 children from two identical, multi-site, double-blind, randomized,…
Descriptors: Safety, Hyperactivity, Attention Deficit Disorders, Rating Scales